4 ms·

This is quite the display of unnecessary credentialism. It’s a blog. A nicely-designed and seemingly useful one at that (I’m finding this post on IBS to be a ha

This is quite the display of unnecessary credentialism. It’s a blog. A nicely-designed and seemingly useful one at that (I’m finding this post on IBS to be a handy summary and pointer to studies: https://trevorklee.com/a-complete-guide-to-self-diagnosing-and-self-treating-ibs/ https://trevorklee.com/a-complete-guide-to-self-diagnosing-a...). From what I can tell, this is a humble, curious, and well-meaning guy that funds his menagerie of research interests with a successful tutoring business (a noble career in and of itself). I see absolutely no need to frame him as an unworthy crank.

meowface 5y ago
I don't think the parent was taking much issue with the blog posts or the fact that he's a tutor. I think it's his previous companies, plus this paragraph from the post: > So, first of all, the confession: I’m not a neutral observer here. In talking about this paper, I’m talking my own book. My company, Highway Pharmaceuticals, is currently raising funds to get a safer, easier to use, extended-release version of cyclosporine, the most common calcineurin inhibitor, into first-in-human trials. If this paper is correct, investors should probably consider throwing money at me.
- caymanjim 5y ago
  Yes, this. I enjoyed the blog post. It was an easy read, the idea is intriguing, it linked to a related paper. I found the plug for the company mildly offputting, and decided to see if the author was someone actively working in this space. I don't think anyone needs credentials to have an interesting idea, but it's laughable that someone with no lab or research or business experience is an actual player in this space. I guess people can invest in him if they want. The idea that he's fundraising for human trials is laughable.
  - mcguire 5y ago
    As they say, ideas are easy. Execution is hard.
deleted 5y ago
[deleted]

meowface 5y ago

I don't think the parent was taking much issue with the blog posts or the fact that he's a tutor. I think it's his previous companies, plus this paragraph from the post: > So, first of all, the confession: I’m not a neutral observer here. In talking about this paper, I’m talking my own book. My company, Highway Pharmaceuticals, is currently raising funds to get a safer, easier to use, extended-release version of cyclosporine, the most common calcineurin inhibitor, into first-in-human trials. If this paper is correct, investors should probably consider throwing money at me.

caymanjim 5y ago
Yes, this. I enjoyed the blog post. It was an easy read, the idea is intriguing, it linked to a related paper. I found the plug for the company mildly offputting, and decided to see if the author was someone actively working in this space. I don't think anyone needs credentials to have an interesting idea, but it's laughable that someone with no lab or research or business experience is an actual player in this space. I guess people can invest in him if they want. The idea that he's fundraising for human trials is laughable.
- mcguire 5y ago
  As they say, ideas are easy. Execution is hard.

deleted 5y ago

[deleted]